Brief: Xeris Biopharma Q4 Product Revenue USD 83.43 Million Versus. Ibes Estimate USD 82.3 Million

Xeris Biopharma Holdings

02/03/2026 14:01

March 2 (Reuters) - Xeris Biopharma Holdings Inc XERS.O:

XERIS BIOPHARMA Q4 OPERATING INCOME USD 16.773 MILLION

XERIS BIOPHARMA Q4 PRODUCT REVENUE USD 83.43 MILLION VERSUS. IBES ESTIMATE USD 82.3 MILLION

XERIS BIOPHARMA Q4 EPS USD 0.06

XERIS BIOPHARMA Q4 NET INCOME USD 11.081 MILLION

EXPECTS 2026 REVENUE BETWEEN $375 MILLION AND $390 MILLION

FY2026 REVENUE VIEW $368.1 MILLION -- LSEG IBES DATA

Source text: ID:nBw6df2Bwa

Further company coverage: XERS.O

 ((Reuters.Briefs@thomsonreuters.com;))